China Shineway Pharmaceutical Group Limited (C1S) — Tangible Net Worth Ratio
China Shineway Pharmaceutical Group Limited (C1S) has a Tangible Net Worth Ratio of 99.8% as of December 2025. This metric is calculated by deducting intangible assets (€15.72 Million) from net assets (€8.06 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See what is China Shineway Pharmaceutical Group Limi's book value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
China Shineway Pharmaceutical Group Limited Tangible Net Worth Ratio (2013–2025)
This chart shows how China Shineway Pharmaceutical Group Limited's Tangible Net Worth Ratio has changed across 13 annual periods from 2013 to 2025. As of December 2025, the ratio stands at 99.8%, reflecting net assets of €8.06 Billion with intangible assets of €15.72 Million EUR. Also explore C1S year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for China Shineway Pharmaceutical Group Limited (2013–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for China Shineway Pharmaceutical Group Limited from 2013 to 2025, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see China Shineway Pharmaceutical Group Limi (C1S) total market value.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.8% | €8.06 Billion | €15.72 Million | €10.78 Billion | ▲ +0.1 pp |
| 2024 | 99.7% | €7.47 Billion | €23.32 Million | €10.04 Billion | ▲ +0.2 pp |
| 2023 | 99.5% | €7.03 Billion | €32.79 Million | €9.57 Billion | ▲ +0.3 pp |
| 2022 | 99.3% | €6.38 Billion | €47.35 Million | €8.23 Billion | ▲ +0.4 pp |
| 2021 | 98.9% | €5.90 Billion | €66.43 Million | €7.20 Billion | ▼ -0.5 pp |
| 2020 | 99.4% | €5.79 Billion | €36.96 Million | €7.21 Billion | ▲ +3.7 pp |
| 2019 | 95.7% | €5.78 Billion | €248.27 Million | €7.13 Billion | ▲ +0.7 pp |
| 2018 | 95.0% | €5.77 Billion | €287.92 Million | €6.73 Billion | ▲ +0.3 pp |
| 2017 | 94.7% | €5.82 Billion | €307.96 Million | €6.67 Billion | ▲ +0.9 pp |
| 2016 | 93.8% | €5.63 Billion | €348.35 Million | €6.47 Billion | ▲ +1.1 pp |
| 2015 | 92.7% | €5.30 Billion | €388.74 Million | €6.15 Billion | ▼ -6.9 pp |
| 2014 | 99.5% | €4.89 Billion | €23.29 Million | €5.91 Billion | ▼ -0.5 pp |
| 2013 | 100.0% | €4.43 Billion | €518.00K | €5.74 Billion | — |